Semaglutide may cut Alzheimer's risk in type 2 diabetes

When compared to seven other anti-diabetic drugs, semaglutide may significantly lower the risk of Alzheimer's disease in people with type 2 diabetes, according to new research from the Case Western Reserve School of Medicine.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...